Evidence map›Paper›PMID 33171898›Full record

ReviewMaterials (Basel, Switzerland)2020

A Review on Chitosan's Uses as Biomaterial: Tissue Engineering, Drug Delivery Systems and Cancer Treatment.

Rayssa de Sousa Victor, Adillys Marcelo da Cunha Santos, Bianca Viana de Sousa, Gelmires de Araújo Neves, Lisiane Navarro de Lima Santana, Romualdo Rodrigues Menezes

Open access · goldAbstract readReview
In one paragraph

Review in Materials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed, 1 pooled it
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 1 synthesis or guideline pooled it, 225 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Rayssa de Sousa VictorGraduate Program in Materials Science and Engineering, Laboratory of Materials Technology (LTM), Federal University of Campina Grande, Campina Grande 58429-900, Brazil.ORCID 0000-0002-8008-2434
Adillys Marcelo da Cunha SantosCenter for Science and Technology in Energy and Sustainability (CETENS), Federal University of Recôncavo da Bahia (UFRB), Feira de Santana 44042-280, Brazil.
Bianca Viana de SousaDepartment of Chemical Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil.
Gelmires de Araújo NevesLaboratory of Materials Technology (LTM), Department of Materials Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil.
Lisiane Navarro de Lima SantanaLaboratory of Materials Technology (LTM), Department of Materials Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil.
Romualdo Rodrigues MenezesLaboratory of Materials Technology (LTM), Department of Materials Engineering, Federal University of Campina Grande, Campina Grande 58429-900, Brazil.ORCID 0000-0003-4316-2168
Universidade Federal de Campina Grande · BRUniversidade Federal do Recôncavo da Bahia · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 308822/2018-8Conselho Nacional de Desenvolvimento Científico e Tecnológico 420004/2018-1Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88887.463851/2019-00
6 · The paper itself

Abstract

Chitosan, derived from chitin, is a biopolymer consisting of arbitrarily distributed β-(1-4)-linked D-glucosamine and N-acetyl-D-glucosamine that exhibits outstanding properties- biocompatibility, biodegradability, non-toxicity, antibacterial activity, the capacity to form films, and chelating of metal ions. Most of these peculiar properties are attributed to the presence of free protonable amino groups along the chitosan backbone, which also gives it solubility in acidic conditions. Moreover, this biopolymer can also be physically modified, thereby presenting a variety of forms to be developed. Consequently, this polysaccharide is used in various fields, such as tissue engineering, drug delivery systems, and cancer treatment. In this sense, this review aims to gather the state-of-the-art concerning this polysaccharide when used as a biomaterial, providing information about its characteristics, chemical modifications, and applications. We present the most relevant and new information about this polysaccharide-based biomaterial's applications in distinct fields and also the ability of chitosan and its various derivatives to selectively permeate through the cancer cell membranes and exhibit anticancer activity, and the possibility of adding several therapeutic metal ions as a strategy to improve the therapeutic potential of this polymer.

Indexed as

biopolymercancer treatmentchitosandrug delivery systemtissue engineering

Identifiers

PMID33171898
PMCPMC7664280
OpenAlexW3095097128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.